Suppr超能文献

细胞应激过程中丝氨酸蛋白酶抑制剂 A3 的瞬时反应。

Transient response of serpinA3 during cellular stress.

机构信息

Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.

Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

出版信息

FASEB J. 2022 Mar;36(3):e22190. doi: 10.1096/fj.202101912R.

Abstract

We demonstrated that serpinA3c/k relocates from the cytoplasm to the apical tubular membrane (ATM) in chronic kidney disease (CKD), suggesting its secretion in luminal space in pathophysiological contexts. Here, we studied serpinA3c/k expression and secretion under different stressful conditions in vitro and in vivo. HEK-293 cells were transfected with a FLAG-tagged serpinA3c/k clone and exposed to H O or starvation. Both stressors induced serpinA3c/k secretion but with a higher molecular weight. Glycanase treatment established that serpinA3c/k is glycosylated. Site-directed mutagenesis for each of the four glycosylation sites was performed. During cellular stress, serpinA3c/k secretion increased with each mutant except in the quadruple mutant. In rats and patients suffering acute kidney injury (AKI), an atypical urinary serpinA3c/k excretion (uSerpinA3c/k) was observed. In rats with AKI, the greater the induced kidney damage, the greater the uSerpinA3 c/k, together with relocation toward ATM. Our findings show that: (1) serpinA3c/k is glycosylated and secreted, (2) serpinA3c/k secretion increases during cellular stress, (3) its appearance in urine reveals a pathophysiological state, and (4) urinary serpinA3 excretion could become a potential biomarker for AKI.

摘要

我们证明,丝氨酸蛋白酶抑制剂 A3c/k 在慢性肾脏病(CKD)中从细胞质重新定位到顶端管状膜(ATM),表明其在病理生理环境中在腔空间分泌。在这里,我们研究了丝氨酸蛋白酶抑制剂 A3c/k 在体外和体内不同应激条件下的表达和分泌。用 FLAG 标记的丝氨酸蛋白酶抑制剂 A3c/k 克隆转染 HEK-293 细胞,并暴露于 H 2 O 2 或饥饿。这两种应激源都诱导丝氨酸蛋白酶抑制剂 A3c/k 分泌,但分子量更高。糖基酶处理证实丝氨酸蛋白酶抑制剂 A3c/k 是糖基化的。对每个四个糖基化位点进行了定点突变。在细胞应激期间,除四重突变体外,每个突变体的丝氨酸蛋白酶抑制剂 A3c/k 分泌都增加。在急性肾损伤(AKI)的大鼠和患者中,观察到一种非典型的尿丝氨酸蛋白酶抑制剂 A3c/k 排泄(uSerpinA3c/k)。在 AKI 大鼠中,诱导的肾脏损伤越大,uSerpinA3 c/k 越大,同时向 ATM 重新定位。我们的研究结果表明:(1)丝氨酸蛋白酶抑制剂 A3c/k 是糖基化和分泌的,(2)丝氨酸蛋白酶抑制剂 A3c/k 在细胞应激期间分泌增加,(3)其在尿液中的出现揭示了一种病理生理状态,(4)尿丝氨酸蛋白酶抑制剂 A3 的排泄可能成为 AKI 的潜在生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验